サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402761

欧州のオルガノイド市場の2030年までの予測-地域別分析：臓器タイプ別、用途別、供給源別、タイプ別

Europe Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type
出版日: | 発行: The Insight Partners | ページ情報: 英文 99 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
欧州のオルガノイド市場の2030年までの予測-地域別分析：臓器タイプ別、用途別、供給源別、タイプ別
出版日: 2023年11月20日
発行: The Insight Partners
ページ情報: 英文 99 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のオルガノイド市場は、2022年の8億4,219万米ドルから2030年には40億8,052万米ドルに成長すると予測されています。2022年から2030年までのCAGRは21.8%と推定されます。

欧州のオルガノイド市場における個別化医療の採用拡大

個別化医療は精密医療とも呼ばれ、予測される反応や病気のリスクに基づいて個々の患者に合わせた処置や薬剤を実践する医療モデルです。個別化医療連合（PMC）が発表した研究によると、個別化医療は2005年にはFDAが承認した新規分子実体のわずか5%に過ぎなかったが、2016年には25%以上を占めるようになった。さらに、全化合物の42％、パイプラインにあるがん領域の化合物の73％が個別化医療になる可能性があります。さらに、バイオ医薬品企業は、個別化医薬品への研究開発投資を過去5年間でほぼ倍増させており、今後5年間で33％増加すると見られています。バイオ医薬品の研究者も、今後5年間で個別化医薬品の開発が69％増加すると予測しています。

個別化薬物療法を生み出すためのオルガノイドの導入は、患者ケアを改善するエキサイティングな機会を提供します。さらに、薬剤師は、精密医療について積極的に教育し、意識を高めることで、個別化医薬品の需要拡大に不可欠な役割を果たしています。最近の調査では、50％以上の消費者がカスタマイズされた製品やサービスの購入に関心を持っていることが明らかになった。この需要は、医薬品をより安全で効果的なものにするため、よりカスタマイズされた治療法を開発するよう製薬研究を説得しています。

個別化がん医療は、腫瘍のゲノム的特徴に従って、患者ごとに効果的な治療戦略を調整するアプローチです。前臨床におけるゲノムの薬物反応予測の機能的側面を確認するために、個別化腫瘍モデリングの調査に対する需要が高まっています。遺伝子と薬剤の関連治療、新しい治療法の同定、患者の転帰の予測などの観点から、個別化がん医療における腫瘍オルガノイドの応用が、数多くの研究で強調されています。

個別化がん治療では、それぞれの患者に特異的な治療が適用されます。元の腫瘍と類似した特徴を持つ個別化腫瘍モデルを用いることで、患者の薬物反応を正確に予測できる可能性があります。腫瘍オルガノイドモデルには、既存のモデルよりも元の腫瘍の分子・細胞組成を保存できるなど、いくつかの利点があります。これらの利点は、特に前臨床薬物スクリーニングや選択した治療レジメンに対する患者の反応予測など、個別化がん治療における腫瘍オルガノイドの大きな可能性を浮き彫りにしています。

欧州のオルガノイド市場概要

欧州のオルガノイド市場は、ドイツ、フランス、イタリア、英国、スペイン、その他欧州に細分化されます。この地域の市場成長は、組織工学と臓器移植の需要の高まり、疾患モデリング、遺伝子変異、腫瘍モデリングのためのオルガノイド採用の増加、オルガノイドに関する研究活動の活発化に関連しています。さらに、資金調達の増加や官民投資などの要因も、この地域の今後数年間のビジネスチャンスを拡大させる可能性が高いです。

欧州のオルガノイド市場の収益と2030年までの予測（金額）

欧州のオルガノイド市場のセグメンテーション

欧州のオルガノイド市場は、臓器タイプ、タイプ、用途、供給源、国に区分されます。

臓器タイプに基づき、欧州のオルガノイド市場は腸、肝臓、胃、膵臓、肺、脳、腎臓、その他に区分されます。腸セグメントが2022年の欧州のオルガノイド市場で最大のシェアを占めました。

タイプ別では、欧州のオルガノイド市場は機器、消耗品、サービスに区分されます。消耗品セグメントは2022年に欧州のオルガノイド市場で最大のシェアを占めました。

用途別では、欧州のオルガノイド市場は発生生物学、感染症の疾患病状、再生医療、薬剤毒性・有効性試験、創薬・個別化医療、その他に区分されます。発生生物学セグメントは、2022年の欧州のオルガノイド市場で最大のシェアを占めました。

供給源に基づき、欧州のオルガノイド市場は多能性幹細胞と臓器特異的成体幹細胞に二分されます。多能性幹細胞セグメントは2022年の欧州のオルガノイド市場でより大きなシェアを占めました。

国別に見ると、欧州のオルガノイド市場はドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。2022年の欧州のオルガノイド市場はドイツが独占しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 欧州の主要洞察
  • 欧州市場の魅力

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のオルガノイド市場情勢

  • 概観
  • 欧州のPEST分析

第5章 欧州のオルガノイド市場-主な産業力学

  • 主な市場促進要因
    • 腫瘍モデリングとバイオバンクの需要増加
    • 個別化医薬品の採用拡大
    • 動物実験モデルの代替品開発への注目の高まり
  • 主な市場抑制要因
    • 既存のワークフローへのオルガノイドの組み込みに関する問題
    • 熟練した専門家の不足
  • 主な市場機会
    • 創薬活動の重視
  • 今後の動向
    • オルガノイドとOrgan-On-A-Chipの組み合わせ
  • インパクト分析

第6章 オルガノイド市場：欧州市場分析

  • 欧州のオルガノイド市場の収益、2022年～2030年

第7章 欧州のオルガノイド市場-収益と2030年までの予測：臓器タイプ別

  • 臓器タイプ別
  • 欧州のオルガノイド市場の収益シェア：臓器タイプ別、2022年・2030年（%）
  • 胃
  • 腸
  • 肝臓
  • 膵臓
  • 肺
  • 脳
  • 腎臓
  • その他

第8章 欧州のオルガノイド市場-収益と2030年までの予測：用途別

  • 欧州のオルガノイド市場の収益シェア：用途別、2022年・2030年（%）
  • 発生生物学
  • 感染症の疾患病状
  • 再生医療
  • 薬物毒性・有効性試験
  • 創薬・個別化医療
  • その他

第9章 欧州のオルガノイド市場-収益と2030年までの予測：供給源別

  • 欧州のオルガノイド市場の収益シェア：供給源別、2022年・2030年（%）
  • 多能性幹細胞
  • 臓器特異的成体幹細胞

第10章 欧州のオルガノイド市場-収益と2030年までの予測：タイプ別

  • 欧州のオルガノイド市場の収益シェア：タイプ別、2022年・2030年（%）
  • 機器
  • 消耗品
  • サービス

第11章 欧州のオルガノイド市場：国別分析

第12章 COVID-19前後の影響

  • COVID-19前後の影響

第13章 欧州のオルガノイド市場：業界情勢

  • 市場参入企業の成長戦略（%）
  • 有機的発展
  • 無機的発展

第14章 欧州のオルガノイド市場：主要企業プロファイル

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Hubrecht Organoid Technology
  • Definigen
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • InSphero

第15章 付録

図表

List Of Tables

  • Table 1. Europe Organoids Market Segmentation
  • Table 2. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 8. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 15. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 16. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 17. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 18. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 19. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 20. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 21. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 22. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 23. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 24. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 25. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 26. Organic Developments Done by Companies
  • Table 27. Inorganic Developments Done by Companies
  • Table 28. Glossary of Terms, Europe Organoids Market

List Of Figures

  • Figure 1. Europe Organoids Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Europe Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Organoids Market, By Country - Revenue (2022) ($Mn)
  • Figure 30. Europe Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 31. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 32. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Pre & Post COVID-19 Impact
  • Figure 38. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00018856

The Europe organoids market is expected to grow from US$ 842.19 million in 2022 to US$ 4,080.52 million by 2030. It is estimated to grow at a CAGR of 21.8% from 2022 to 2030.

Growing Adoption of Personalized Drugs in Europe Organoids Market

Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to a study published by Personalized Medicine Coalition (PMC), personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, which is likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years.

The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. Recent research has highlighted that more than 50% of consumers are interested in purchasing customized products or services. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.

Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor's genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.

Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

Europe Organoids Market Overview

The Europe organoids market is sub-segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The regional market growth is associated with the rising demand for tissue engineering and organ transplantation; increasing adoption of organoids for disease modeling, gene mutation, and tumor modeling; and growing research activities on organoids. In addition, factors such as increased funding and public-private investments will likely add more opportunities in the coming years in the region.

Europe Organoids Market Revenue and Forecast to 2030 (US$ Million)

Europe Organoids Market Segmentation

The Europe organoids market is segmented into organ type, type, application, source, and country.

Based on organ type, the Europe organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the Europe organoids market in 2022.

Based on type, the Europe organoids market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the Europe organoids market in 2022.

Based on application, the Europe organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the Europe organoids market in 2022.

Based on source, the Europe organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the Europe organoids market in 2022.

Based on country, the Europe organoids market is segmented into the Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. Germany dominated the Europe organoids market in 2022.

Cellesce, Definigen, Hubrecht Organoid Technology, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Europe Key Insights
  • 2.2 Europe Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Organoids Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis

5. Europe Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - Europe Market Analysis

  • 6.1 Europe Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Europe Organoids Market - Revenue and Forecast to 2030 - by Organ Type

  • 7.1 Overview
  • 7.2 Europe Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Europe Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 Europe Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 Europe Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Organoids Market - Country Analysis

  • 11.1 Europe Organoids Market: Overview
    • 11.1.1 Europe Organoids Market by Country
      • 11.1.1.1 Germany
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.3 Germany Organoids Market, by Organ Type
        • 11.1.1.1.4 Germany Organoids Market, by Application
        • 11.1.1.1.5 Germany Organoids Market, by Source
        • 11.1.1.1.6 Germany Organoids Market, by Type
      • 11.1.1.2 UK
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.3 UK Organoids Market, by Organ Type
        • 11.1.1.2.4 UK Organoids Market, by Application
        • 11.1.1.2.5 UK Organoids Market, by Source
        • 11.1.1.2.6 UK Organoids Market, by Type
      • 11.1.1.3 France
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.3 France Organoids Market, by Organ Type
        • 11.1.1.3.4 France Organoids Market, by Application
        • 11.1.1.3.5 France Organoids Market, by Source
        • 11.1.1.3.6 UK Organoids Market, by Type
      • 11.1.1.4 Italy
        • 11.1.1.4.1 Overview
        • 11.1.1.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.3 Italy Organoids Market, by Organ Type
        • 11.1.1.4.4 Italy Organoids Market, by Application
        • 11.1.1.4.5 Italy Organoids Market, by Source
        • 11.1.1.4.6 Italy Organoids Market, by Type
      • 11.1.1.5 Spain
        • 11.1.1.5.1 Overview
        • 11.1.1.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.5.3 Spain Organoids Market, by Organ Type
        • 11.1.1.5.4 Spain Organoids Market, by Application
        • 11.1.1.5.5 Spain Organoids Market, by Source
        • 11.1.1.5.6 Spain Organoids Market, by Type
      • 11.1.1.6 Rest of Europe
        • 11.1.1.6.1 Overview
        • 11.1.1.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.6.3 Rest of Europe Organoids Market, by Organ Type
        • 11.1.1.6.4 Rest of Europe Organoids Market, by Application
        • 11.1.1.6.5 Rest of Europe Organoids Market, by Source
        • 11.1.1.6.6 Rest of Europe Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post COVID-19 Impact

13. Europe Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Europe Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Hubrecht Organoid Technology
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Definigen
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Thermo Fisher Scientific Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.7 InSphero
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms